|
|
| n (%) |
|
| Characteristics | MDR-TB N = 24 | Pre-XDR or XDR-TB N-10 | p-value |
| Therapy type |
|
|
|
| No directly ibserved and self-adminstered Directly observed only Self-administered only Combination directly ibserved and self-adminstered | 2 (8.3) 3 (12.5) 4 (16.7) 15 (62.5) | 2 (20.0) 1 (10.0) 2 (20.0) 5 (50.0) | 0.872 |
| Treatment patterns |
|
|
|
| No treatment CAT IV (I) CAT IV (II) CAT V Only INH | 2 (8.3) 13 (54.2) 9 (37.5) 0 (0.0) 0 (0.0) | 2 (20.0) 4 (40.0) 2 (20.0) 1 (10.0) 1 (10.0) | 0.112 |
| Period of treatment (months) |
|
|
|
| <6.0 6.1 - 12.0 12.0 - 24.0 >24.0 Min Max Mean (SD) | 5 (20.8) 3 (12.5) 7 (29.2) 9 (37.5) 0 48.3 20.1 (1.4) | 2 (20.0) 2 (20.0) 3 (30.0) 3 (30.0) 2.3 51.1 18.3 (14.4) | 0.952 |
| Major side effects |
|
|
|
| No yes | 8 (33.3) 16 (66.7) | 6 (60.0) 4 (40.0) | 0.252 |
| Minor side effect |
|
|
|
| No Yes | 6 (25.0) 18 (75.0) | 7 (70.0) 3 (30.0) | 0.020 |